1. Home
  2. MDXH vs HSDT Comparison

MDXH vs HSDT Comparison

Compare MDXH & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • HSDT
  • Stock Information
  • Founded
  • MDXH 2003
  • HSDT N/A
  • Country
  • MDXH Belgium
  • HSDT United States
  • Employees
  • MDXH N/A
  • HSDT N/A
  • Industry
  • MDXH
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MDXH
  • HSDT Health Care
  • Exchange
  • MDXH Nasdaq
  • HSDT Nasdaq
  • Market Cap
  • MDXH 203.4M
  • HSDT 194.2M
  • IPO Year
  • MDXH 2021
  • HSDT N/A
  • Fundamental
  • Price
  • MDXH $3.28
  • HSDT $3.40
  • Analyst Decision
  • MDXH Strong Buy
  • HSDT
  • Analyst Count
  • MDXH 3
  • HSDT 0
  • Target Price
  • MDXH $7.67
  • HSDT N/A
  • AVG Volume (30 Days)
  • MDXH 333.0K
  • HSDT 710.6K
  • Earning Date
  • MDXH 11-12-2025
  • HSDT 11-18-2025
  • Dividend Yield
  • MDXH N/A
  • HSDT N/A
  • EPS Growth
  • MDXH N/A
  • HSDT N/A
  • EPS
  • MDXH N/A
  • HSDT N/A
  • Revenue
  • MDXH $103,069,000.00
  • HSDT $295,000.00
  • Revenue This Year
  • MDXH $24.78
  • HSDT N/A
  • Revenue Next Year
  • MDXH $21.20
  • HSDT $75.13
  • P/E Ratio
  • MDXH N/A
  • HSDT N/A
  • Revenue Growth
  • MDXH 21.68
  • HSDT N/A
  • 52 Week Low
  • MDXH $1.35
  • HSDT $3.25
  • 52 Week High
  • MDXH $5.33
  • HSDT $1,200.00
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 26.74
  • HSDT 28.32
  • Support Level
  • MDXH $2.75
  • HSDT $4.33
  • Resistance Level
  • MDXH $4.98
  • HSDT $5.47
  • Average True Range (ATR)
  • MDXH 0.28
  • HSDT 0.56
  • MACD
  • MDXH -0.17
  • HSDT 0.08
  • Stochastic Oscillator
  • MDXH 23.45
  • HSDT 4.43

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About HSDT Helius Medical Technologies Inc. (DE)

Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.

Share on Social Networks: